AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Newborns From Patients Treated With ART (Assisted Reproductive Technology)

Recruitingn/aAges 0 Weeks - 40 YearsAllThe First Affiliated Hospital of Zhengzhou Univerโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The Prospective Cohort Study for Newborns from patients treated with ART was set up to investigate the short- and long-term health consequences in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, China.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * All newborns from patients treated with ART in our center. Exclusion Criteria: \-
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy